News Releases

RNAissance Ag Names Steve Meyer New CEO

by Animal Health2 | Oct 12, 2022

Deeply experienced agtech leader sees opportunity in company’s portfolio of safe, specific and  effective biopesticides and novel RNAi manufacturing technology. 

KANSAS CITY, Mo.—Oct. 12, 2022—TechAccel LLC, the technology and venture development  company investing in scientific breakthroughs for healthier plants, animals and foods, today  announced that Steven Meyer has joined its subsidiary RNAissance Ag LLC as Chief Executive  Officer, effective immediately.  

Steve-Meyer-300x300Meyer most recently was chief operating officer at Lucy Scientific Discovery Inc., British  Columbia, a cGMP manufacturer of psychotropic compounds for therapeutic uses. Prior to this  role, he was the co-founder and CEO of Heya Wellness of St. Charles, Mo., a vertically  integrated medical cannabis firm.  

He worked the previous 16 years at Monsanto (now Bayer Crop Science) in a variety of  scientific and commercial roles. He conducted biotechnology research that led to the  development of multiple commercial products and played a key role in transforming the firm’s  insect control discovery pipeline, leading to his appointment as a Monsanto Science Fellow. He  also served as Operations Lead for North America Knowledge Transfer, where he was  responsible for developing and executing strategies to deliver agronomy support to commercial  field teams and customers.  

“Steve has the expertise and leadership to drive the RNAissance Ag technology – both in  biomanufacturing and biopesticide development – to commercial success,” said Michael  Helmstetter, Ph.D., Chairman of the RNAissance Ag Board of Directors and TechAccel founder  and president. “Plus, he has an innovator’s mindset and draws upon an extraordinary range of  experiences and insights. We can’t wait to start working with him.” 

RNAissance Ag, which is in the process of expanding its office and lab facilities at BRDG Park  in St. Louis, is a startup founded in 2019 by TechAccel based on a novel RNA-interference  (RNAi) technology developed at the Donald Danforth Plant Science Center. RNAi is a  technology that regulates gene expression without genetic modification.  

The primary focus of RNAissance Ag is the development of sprayable RNAi pesticides against  pests such as the Diamondback Moth, Fall Armyworm and several others. RNAissance Ag  pesticides are designed to be highly specific to the target pest, are not toxic to other organisms and are biodegradable. RNAissance Ag’s designs also have applications as pesticidal traits in crop seeds. 

“I am excited and honored to join RNAissance Ag as its CEO,” Meyer said. “I am very  impressed by the quality and caliber of the team, which is at the heart of every great company. I  believe the full potential of RNAi-based solutions in agriculture is yet to be seen. This innovative  technology not only has the potential to offer a much-needed new tool to solve some of the  toughest challenges we face in agriculture, but it also promises to revolutionize sustainable  agriculture, making it safer for people and our planet.”  

Meyer has a master’s degree in biological sciences from Washington University and a  bachelor’s in biological sciences from Lindenwood University. An entrepreneur and scientist, he  is passionate about agricultural sustainability and ethnopharmacology, the exploration and  understanding of medicinal uses of plants.  

About RNAissance Ag 
RNAissance Ag LLC was formed in January 2019 by TechAccel. The company holds the  exclusive license to proprietary RNAi technology developed at the Donald Danforth Plant  Science Center that has promise to be effective for insect pests that previously were considered resistant to RNAi.  

About TechAccel 
TechAccel LLC was founded in 2014 as a technology and venture development organization in  the agriculture, animal health and foodtech sectors. TechAccel sources, acquires and invests in  early-stage innovation. Through collaborations with universities and research institutions,  TechAccel conducts advancement and de-risking research and development to ready  technologies for market adoption and commercialization. TechAccel also makes equity  investments in start-up companies through its Equity+TM program where an adjacent business opportunity exists. For more information, visit Follow us on Twitter at @Tech_Accel




Tweet @AHCorridor

Media Coverage

The Connector

KC Animal Health Blog